These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 12860959)

  • 1. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.
    Ripamonti C; Brunelli C
    J Clin Oncol; 2003 Jul; 21(14):2801-2; author reply 2802-3. PubMed ID: 12860959
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized clinical trial of an implantable drug delivery system.
    Davis MP; Walsh D; Lagman R; LeGrand SB
    J Clin Oncol; 2003 Jul; 21(14):2800-1; author reply 2802-3. PubMed ID: 12860958
    [No Abstract]   [Full Text] [Related]  

  • 3. Intracerebroventricular morphine for refractory cancer pain: transitioning to the home setting.
    Adolph MD; Stretanski MF; McGregor JM; Rawn BL; Ross PM; Benedetti C
    Am J Hosp Palliat Care; 2010 Aug; 27(5):326-32. PubMed ID: 20103784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices.
    Stearns L; Boortz-Marx R; Du Pen S; Friehs G; Gordon M; Halyard M; Herbst L; Kiser J
    J Support Oncol; 2005; 3(6):399-408. PubMed ID: 16350425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM).
    Smith TJ; Coyne PJ; Staats PS; Deer T; Stearns LJ; Rauck RL; Boortz-Marx RL; Buchser E; Català E; Bryce DA; Cousins M; Pool GE
    Ann Oncol; 2005 May; 16(5):825-33. PubMed ID: 15817596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intrathecal implantable infusion pumps in the treatment of refractory pain--report of 3 cases].
    Wang RZ; Tao W; Ren ZY; Su CB; Yang Y; Zhang B; Ma WB; Yang Z; Gong ZY; Ye TH
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1746-9. PubMed ID: 15569443
    [No Abstract]   [Full Text] [Related]  

  • 7. Challenges associated with spinal opioid therapy for pain in patients with advanced cancer: a report of three cases.
    Yennurajalingam S; Dev R; Walker PW; Reddy SK; Bruera E
    J Pain Symptom Manage; 2010 May; 39(5):930-5. PubMed ID: 20471553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death after initiation of intrathecal drug therapy for chronic pain: assessing risk and designing prevention.
    Rathmell JP; Miller MJ
    Anesthesiology; 2009 Oct; 111(4):706-8. PubMed ID: 20029248
    [No Abstract]   [Full Text] [Related]  

  • 9. Two decades of improved pain control.
    Penn RD
    J Support Oncol; 2005; 3(6):411-2. PubMed ID: 16350426
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrathecal narcotic infusion pumps for intractable pain of chronic pancreatitis: a pilot series.
    Kongkam P; Wagner DL; Sherman S; Fogel EL; Whittaker SC; Watkins JL; McHenry L; Lehman GA
    Am J Gastroenterol; 2009 May; 104(5):1249-55. PubMed ID: 19367269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of cancer pain with continuous opioid via spinal catheters].
    Skadborg MK; Behrens JK; Felsby S; Carlsson PS
    Ugeskr Laeger; 1994 Apr; 156(14):2070-8. PubMed ID: 7516100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
    Lin CP; Lin WY; Lin FS; Lee YS; Jeng CS; Sun WZ
    J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of severe cancer pain via spinal catheters].
    Andersen JS; Markers PI; Valentin N
    Ugeskr Laeger; 1996 Nov; 158(46):6613-6. PubMed ID: 8966828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients.
    Mercadante SL; Berchovich M; Casuccio A; Fulfaro F; Mangione S
    Am J Hosp Palliat Care; 2007; 24(1):13-9. PubMed ID: 17347500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in psychosocial outcomes in chronic pain patients receiving intrathecal morphine infusions.
    Duse G; Davià G; White PF
    Anesth Analg; 2009 Dec; 109(6):1981-6. PubMed ID: 19923529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients.
    Dudgeon DJ; Bruera E; Gagnon B; Watanabe SM; Allan SJ; Warr DG; MacDonald SM; Savage C; Tu D; Pater JL
    J Pain Symptom Manage; 2007 Apr; 33(4):365-71. PubMed ID: 17397698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Continuous spinal analgesia in home care of oncologic pain].
    Ricci V; Dalpane A; Lolli E
    Minerva Med; 1995 Oct; 86(10):409-14. PubMed ID: 8622808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain management, including intrathecal pumps.
    Smith TJ; Swainey C; Coyne PJ
    Curr Oncol Rep; 2004 Jul; 6(4):291-6. PubMed ID: 15161583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.